Clinical Trials Logo

Clinical Trial Summary

Introduction and objectives: At the global level, cardiovascular diseases are the leading cause of mortality. Currently, rehabilitation programs are shown as an effective treatment to mitigate the effects of heart failure. The main objective is to compare the effects of aerobic exercise and strength in patients with heart failure after a cardiovascular rehabilitation program.

Methods and materials: Randomized controlled trial over a period of 3 years with patients with heart failure distributed in 3 groups (Aerobic exercise, aerobic exercise plus upper limb -MMSS- training, aerobic exercise plus training of lower limb -MMII-). Blood samples were taken to determine blood glucose levels and lipid profile. In addition, tests for aerobic capacity, maximum heart rate, anthropometry, depression, anxiety, clinical and hemodynamic parameters. The tests were performed before and after 24 training sessions, 60 min, 3 times a week for two months.


Clinical Trial Description

MATERIALS AND METHODS

This research for the group number 1 was retrospective and for groups 2 and 3 it was a randomized controlled trial with a basic probabilistic sampling by means of a table of random numbers, whose order was randomized through the Microsoft Excel 16.0 program, being the group experimental 1 at the end with 253 participants (aerobic exercise without strength training), 256 participants in experimental group 2 (aerobic exercise + strength training in the upper extremities) and control group with 255 (aerobic exercise + strength training for the lower extremities). The present investigation was carried out in a period of 3 years (April 2016-2019) that contains the following attributes:

Characteristics of the participants The participants contained similar characteristics from the point of view of: ejection fraction, functional class, glucose, lipid profile, muscle percentage, fat and BMI (body mass index), abdominal circumference, overweight, obesity, prevalence of diabetes, arterial hypertension (HTA), kidney disease, cardiovascular risk factors and cardiovascular surgical procedure for their respective analysis. In addition, all participants presented "High risk" according to the stratification proposed by the American Association of Cardiopulmonary Rehabilitation. Highlighting that for group 1 their research methodology was retrospective through the collection of data from medical records of the year 2000 and groups 2 and 3 were interventions with methodology of randomized clinical trial between the years 2016 to 2019.

Criteria for inclusion in the study The patients had to be post-operative of cardiovascular surgery that go to a phase II cardiac rehabilitation program, which at the time had to sign an informed consent endorsed by the ethics and research committee of the institution. Likewise, it was necessary for participants to have heart failure with ejection fraction greater than 35%; do not have any inconvenience when doing the questionnaires, tests and measures that the investigation demands, and a commitment to go 3 times a week for RCV.

Exclusion criteria Patients who had severe pain in the lower limbs, unstable angina, heart rate >120 bpm (beats per minute) at rest, systolic blood pressure >190 mmHg, diastolic blood pressure >120 mmHg were discarded. Similarly, patients who had a positive contraindication item for cardiac rehabilitation were not admitted in the study. In addition, the participant had the option of being able to withdraw from the research when he wished or to show hemodynamic instability without improving during any test or during the intervention process.

Anthropometric measurement In all the participants the following data were obtained: Family and personal antecedents using a self-created questionnaire. Likewise, anthropometric measures (weight, height, body mass index, abdominal circumference, fat and muscle percentage) using standardized techniques in the Colombian population.

The weight, fat percentage and muscle, were obtained by using the digital scale previously calibrated and located on a flat and stable surface, using the indications in the user's manual. On the other hand, the size was obtained with the Kramer 2104 Adult Acrylic Wall Height Measurement, placing the patient standing, with the head in Frankfort plane and with the shoulders relaxed to avoid lordosis and MMII completely against the wall. Having said the above, with these variables the BMI was determined in kg/m-1.

Then, with a tape measure and a precision of 1mm, the abdominal circumference measurement was collected taking the anatomical referents described by Frisancho. The "Waist circumference cut points for the diagnosis of abdominal obesity in the Colombian population using bioimpedance as reference standard" were chosen as cutting points: in men 91cm and women 89cm.

Clinical and hemodynamic parameters After all the above procedures, the blood glucose levels were determined on the first and last day of your training session with an Acca-Chek® Perform glucometer following the technical specifications suggested by the manufacturer. The blood sample was taken between 7:00 and 8:00 a.m., after 8-10 hours of fasting. It should be added that the blood samples were collected in the hospital clinical laboratory to define cholesterol levels, triglycerides, low density lipoproteins (LDL) and high density lipoproteins (HDL). Each patient underwent a 2-D (two-dimensional) echocardiography before and after the cardiac rehabilitation program, to visualize the structures, the LVEF and analyze their mobility in real time. In this same evaluation, the functional class of each patient was identified according to the NYHA classification (New York Heart Association); which designates 4 classes (I, II, III and IV) based on the limitations of the patient's physical activity, caused by cardiac symptoms. Similarly, perceived dyspnea and effort were assessed using the modified Borg scale. The heart rate was detected by the Polar Multisport RS800CX system and the respiratory one, just as the systolic and diastolic blood pressure was obtained manually, while the oxygen saturation was obtained with a portable pulse oximeter (Nellcor Puritan Bennett).

Tests and questionnaires From the beginning, the patient underwent a medical assessment by the area of physiatry to understand the current state of the patient, sociodemographic, anthropometric and physiological characteristics. On the same day, tolerance to exercise was estimated by the 6-minute walk test, which was superimposed before and after 24 sessions of cardiac rehabilitation. The protocol of the 6-minute walk test was performed according to the ATS Statement: Guidelines for the six-minute walk test of the American Thoracic Society. On the other hand, to denote the initial weight of strength training for upper limbs (MMSS) and lower limbs (MMII), weights were used in a repetition with increase or decrease of the load of 2.5 to 8 lb, until achieving the maximum weight to lift. A maximum repetition (1RM) was considered appropriate with a full extension of the muscle group used, without muscle substitutions. After this evaluation day, the patient had to return to next day for an effort test according to the Naughton protocol, which is recommended in high-risk patients, with stages of 2 minutes. The patient was told that he should avoid smoking, drinking drinks or any type of drug or medication that could alter his vital signs or performance during the test.

Depression and anxiety The HADS questionnaire (Hospital Anxiety and Depression Scale) was used for anxiety and depression. Regarding anxiety, the questions are aimed at identifying if the user has been tense, worried or with some kind of fear. However, the questions of depression are aimed at identifying if the user shows disinterest in the activities of daily life, negativity about things and their attitude to be happy. At this point it is emphasized that the questionnaire was applied by two independent and blinded investigators (M. D-B and D. P-F); which delivered the questionnaires to two other investigators (R. P-R and L. C-P) for verification and analysis.

Blind methodology A simple blind clinical study was carried out, in which the patients were assessed by a non-research professional (physiatrist of the cardiac rehabilitation service), as well as blood tests. Afterwards, patients accessed a database in Microsoft Excel 16.0 exclusively with an identification number that allowed blinding of the investigators. Blindly, a first investigators (J. P-R) collected the database of 253 patients of total 564 intervened patients in cardiac rehabilitation in the year 2000 and provided the list to three blinded investigators (X. V-B, K. S-P and D. R-G) for form the group number 1. Likewise, the first investigators (J.P-R) captured the result of the assignment of the participants in the 2 cardiac rehabilitation groups and provided the list of experimental groups 2 and 3 to the blinded investigators P. P-R, D. P-F and M. D-B; R. P-R, C. Q-G and L. C-P; respectively.

For the groups 2 and 3, the researchers prepared the questionnaires and tests without them knowing the assignment of each patient. After the tests, participants were suggested to approach cardiac rehabilitation to let them know their schedule and start date to the training program. Ignoring the cardiopulmonary rehabilitators, after 24 training sessions according to the assigned group, they gave an accurate report on the physiological changes and behavior in each training session.

However, the initial tests until the end of the training program the investigators did not establish conversation about the topic with the participants or therapists. Exclusively the investigators J. P-R. held periodic meetings with the cardiopulmonary rehabilitators to be aware and harmonize the training of each group but not intimate with the participants.

After the training program, the tests and tests were carried out to the patients of each group to calculate the post-training changes. Taking into account the information collected pre- and post, the statistical analyzes for experimental group 1 were carried out by X. V-B, K. S-P and D. R-G; experimental group 2 for P. P-R, D. P-F and M. D-B and for the experimental group 3 the authors R. P-R, C. Q-G and L. C-P. Finally, once the different variables were studied in a blinded manner, all the authors were informed about the groups with their corresponding patients and results in order to produce the conclusions.

Intervention by group The cardiac rehabilitation program consisted of 24 sessions of 60 minutes a day (10 minutes of warm-up, 40 minutes of training and 10 minutes of cool down phase), 3 times a week, for two months. With regard to warming, it was based on mobilization exercises by muscle groups. Cool down phase was done with proprioception exercises, stretching coordination and breathing exercises.

Related to the 40 minutes of training, it was modified according to the assigned group, for the experimental group 1, it was supported only in aerobic exercise in endless band and elliptical bicycle (report by medical records). The patients of experimental group 2 performed aerobic exercise in endless band and elliptical bike as group 1 plus strength exercises for upper limbs with dumbbells, multi-strength equipment and Theraband. On the other hand, the training of the control group executed the same order of the experimental group 1 plus the strength training for lower limbs with theraband, multi-strength equipment and exercises for activation of the sole-twin pump.

The work force for aerobic exercise was 50 to 70% of your maximum heart rate (HRM) achieved in the stress test according to the Naughton protocol. For strength, between 30% to 50% of 1 RM was determined, prolonging a percentage of heart rate that did not surpass 70% of the FCM nor the subjective uptake of physical effort to more than 6 on the modified Borg scale. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03913780
Study type Interventional
Source University Tolteca
Contact
Status Completed
Phase N/A
Start date April 2016
Completion date January 2019

See also
  Status Clinical Trial Phase
Recruiting NCT05654272 - Development of CIRC Technologies
Recruiting NCT05650307 - CV Imaging of Metabolic Interventions
Recruiting NCT05196659 - Collaborative Quality Improvement (C-QIP) Study N/A
Active, not recruiting NCT05896904 - Clinical Comparison of Patients With Transthyretin Cardiac Amyloidosis and Patients With Heart Failure With Reduced Ejection Fraction N/A
Completed NCT05077293 - Building Electronic Tools To Enhance and Reinforce Cardiovascular Recommendations - Heart Failure
Recruiting NCT05631275 - The Role of Bioimpedance Analysis in Patients With Chronic Heart Failure and Systolic Ventricular Dysfunction
Enrolling by invitation NCT05564572 - Randomized Implementation of Routine Patient-Reported Health Status Assessment Among Heart Failure Patients in Stanford Cardiology N/A
Enrolling by invitation NCT05009706 - Self-care in Older Frail Persons With Heart Failure Intervention N/A
Recruiting NCT04177199 - What is the Workload Burden Associated With Using the Triage HF+ Care Pathway?
Terminated NCT03615469 - Building Strength Through Rehabilitation for Heart Failure Patients (BISTRO-STUDY) N/A
Recruiting NCT06340048 - Epicardial Injection of hiPSC-CMs to Treat Severe Chronic Ischemic Heart Failure Phase 1/Phase 2
Recruiting NCT05679713 - Next-generation, Integrative, and Personalized Risk Assessment to Prevent Recurrent Heart Failure Events: the ORACLE Study
Completed NCT04254328 - The Effectiveness of Nintendo Wii Fit and Inspiratory Muscle Training in Older Patients With Heart Failure N/A
Completed NCT03549169 - Decision Making for the Management the Symptoms in Adults of Heart Failure N/A
Recruiting NCT05572814 - Transform: Teaching, Technology, and Teams N/A
Enrolling by invitation NCT05538611 - Effect Evaluation of Chain Quality Control Management on Patients With Heart Failure
Recruiting NCT04262830 - Cancer Therapy Effects on the Heart
Completed NCT06026683 - Conduction System Stimulation to Avoid Left Ventricle Dysfunction N/A
Withdrawn NCT03091998 - Subcu Administration of CD-NP in Heart Failure Patients With Left Ventricular Assist Device Support Phase 1
Recruiting NCT05564689 - Absolute Coronary Flow in Patients With Heart Failure With Reduced Ejection Fraction and Left Bundle Branch Block With Cardiac Resynchronization Therapy